AM-3189

AM-3189 is a potent and selective GPR40 agonist with minimal CNS penetration and a favorable pharmacokinetic profile, including low clearance and good oral bioavailability. It is a useful research tool for studying GPR40's role in metabolic diseases like type 2 diabetes, enabling in vitro binding assays and in vivo efficacy studies.